Tamer E. Fandy
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Cell death mechanisms and regulation
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Epigenetics and DNA Methylation 11
- Histone Deacetylase Inhibitors Research 11
- Cancer-related gene regulation 6
- RNA modifications and cancer 4
- Cell death mechanisms and regulation 3
-
- Acute Myeloid Leukemia Research 7
- Co-authors
- Rakesh K. Srivastava (6 shared papers)Sharmila Shankar (4 shared papers)Steven D. Gore (7 shared papers)Anchalee Jiemjit (5 shared papers)Douglas D. Ross (3 shared papers)Hetty E. Carraway (9 shared papers)Hazem E. Hassan (5 shared papers)Edward A. Sausville (1 shared paper)
- Journals
- Blood (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Scientific Reports (2 papers)Molecular Cancer (1 paper)Molecular and Cellular Biochemistry (1 paper)
- Partner nations
- United StatesEgyptChina
In The Last Decade
Tamer E. Fandy
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 104
- Hematology 297
- Molecular Biology 821
- Molecular Medicine 39
- Oncology 195
- Cancer Research 89
Countries citing papers authored by Tamer E. Fandy
This map shows the geographic impact of Tamer E. Fandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer E. Fandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer E. Fandy more than expected).
Fields of papers citing papers by Tamer E. Fandy
This network shows the impact of papers produced by Tamer E. Fandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer E. Fandy. The network helps show where Tamer E. Fandy may publish in the future.
Co-authors
The 25 scholars most cited alongside Tamer E. Fandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 244 | |
| 2 | 2005 | 135 | |
| 3 | 2014 | 78 | |
| 4 | 2008 | 73 | |
| 5 | 2017 | 72 | |
| 6 | 2005 | 72 | |
| 7 | 2006 | 66 | |
| 8 | 2009 | 65 | |
| 9 | 2008 | 62 | |
| 10 | 2004 | 60 | |
| 11 | 2014 | 39 | |
| 12 | 2021 | 36 | |
| 13 | 2020 | 32 | |
| 14 | 2006 | 30 | |
| 15 | 2006 | 28 | |
| 16 | 2015 | 28 | |
| 17 | 2007 | 25 | |
| 18 | 2001 | 21 | |
| 19 | 2015 | 18 | |
| 20 | 2020 | 16 |
About Tamer E. Fandy
Tamer E. Fandy is a scholar working on Molecular Biology, Hematology, Oncology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (11 papers), Acute Myeloid Leukemia Research (7 papers), Cancer-related gene regulation (6 papers), RNA modifications and cancer (4 papers), Cell death mechanisms and regulation (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Hematology (297 citations), Molecular Biology (821 citations), Molecular Medicine (39 citations), Oncology (195 citations) and Cancer Research (89 citations). Tamer E. Fandy has collaborated with scholars based in United States, Egypt and China. Frequent co-authors include Rakesh K. Srivastava, Sharmila Shankar, Steven D. Gore, Anchalee Jiemjit, Douglas D. Ross, Hetty E. Carraway, Hazem E. Hassan, Edward A. Sausville, Jonathan D. Licht and Hugo F. Fernández. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, Scientific Reports, Molecular Cancer and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.